| Biomarker ID | 1748 |
| PMID | 30250996 |
| Year | 2018 |
| Biomarker | miR-1274a |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Validated: PI3K_AT; Predicted: MAPK; Apoptosis; mTOR; P53;Cell cycle; |
| Experiment | Prostate Cancer Vs Benign prostatic hyperplasia |
| Type of Biomarker | Diagnostic |
| Cohort | Rretrospective study of 105 samples (86 PC samples and 19 controls) was performed. 71 had prostate cancer and 15 had Castration Resistant Prostate Cancer (CRPC) |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.784 |
| Accuracy | NA |
| Level Of Significance | p=0.00001 |
| Method Used | rt-QPCR |
| Clinical | No |
| Remarks | The fold change was calculated by the 2^(−ΔΔct* expression) |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |